The vaginal microbiome in health and disease
- PMID: 21757370
- PMCID: PMC3183339
- DOI: 10.1016/j.tem.2011.06.001
The vaginal microbiome in health and disease
Abstract
Infections of the vaginal tract result from perturbations in the complex interactions between the microbiome and the host vaginal ecosystem. Recent data have linked specific vaginal microbes and urogenital infection with preterm birth. Here we discuss how next-generation sequencing-based approaches to study the vaginal microbiome will be important for defining what constitutes an imbalance of the microbiome and the associated host conditions that lead to subsequent infection and disease states. These studies will provide clinicians with reliable diagnostic tools and treatments for women who are at increased risk for vaginal infections, preterm birth, HIV and other sexually acquired diseases, and will provide opportunities for intervention.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Van der Veen F, Fransen L. Drugs for STD management in developing countries: choice, procurement, cost, and financing. Sex Transm Infect. 1998;74(Suppl 1):S166–174. - PubMed
 
- 
    - Darroch JE, Frost JJ. Women’s interest in vaginal microbicides. Fam Plann Perspect. 1999;31:16–23. - PubMed
 
- 
    - Fathalla MF. Vaginal microbicides: a priority need for women’s health. Curr Womens Health Rep. 2003;3:263–264. - PubMed
 
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        